Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced Colitis
Open Access
- 15 December 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (24), 11580-11584
- https://doi.org/10.1158/0008-5472.can-06-3562
Abstract
Inflammatory bowel diseases, chronic inflammatory disorders, have been strongly linked with an increased risk of the development of colorectal cancer. Understanding the etiology of these diseases is pivotal for the improvement of currently available strategies to fight against inflammatory bowel disease, and more importantly, to prevent colorectal cancer. Nuclear factor-erythroid 2–related factor 2 (Nrf2) has been known to be a transcriptional factor which plays a crucial role in cytoprotection against inflammation, as well as oxidative and electrophilic stresses. The aim of this study is to investigate the role of Nrf2 in the regulation of dextran sulfate sodium (DSS)–induced experimental colitis in mice. Nrf2-deficient mice were found to be more susceptible to DSS-induced colitis as shown by the increased severity of colitis following 1 week of oral administration of 1% DSS. The increased severity of colitis in Nrf2(−/−) mice was found to be associated with decreased expression of antioxidant/phase II detoxifying enzymes including heme-oxygenase-1, NAD(P)H-quinone reductase-1, UDP-glucurosyltransferase 1A1, and glutathione S-transferase Mu-1. In addition, proinflammatory mediators/cytokines such as COX-2, inducible nitric oxide, interleukin 1β, interleukin 6, and tumor necrosis factor α were significantly increased in the colonic tissues of Nrf2(−/−) mice compared with their wild-type (Nrf2+/+) counterparts. In summary, we show for the first time that mice lacking Nrf2 are more susceptible to DSS-induced colitis. Our data suggests that Nrf2 could play an important role in protecting intestinal integrity, through regulation of proinflammatory cytokines and induction of phase II detoxifying enzymes. (Cancer Res 2006; 66(24): 11580-4)Keywords
This publication has 18 references indexed in Scilit:
- Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsisJCI Insight, 2006
- Combined Inhibitory Effects of Curcumin and Phenethyl Isothiocyanate on the Growth of Human PC-3 Prostate Xenografts in Immunodeficient MiceCancer Research, 2006
- Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in miceThe Journal of Experimental Medicine, 2005
- Super-induction of HO-1 in macrophages stimulated with lipopolysaccharide by prior depletion of glutathione decreases iNOS expression and NO productionNitric Oxide, 2005
- Inflammation as a tumor promoter in cancer inductionSeminars in Cancer Biology, 2004
- At the Crossroads of Inflammation and CancerCell, 2004
- Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- The transcription factor NRF2 protects against pulmonary fibrosisThe FASEB Journal, 2004
- Inflammation and cancerNature, 2002
- The Risk of Colorectal Cancer in Ulcerative Colitis: An Epidemiologic StudyScandinavian Journal of Gastroenterology, 1987